Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    vTv Therapeutics Inc.

    NASDAQ: VTVT · Real-Time Price · USD
    14.99
    -0.07 (-0.46%)
    At close: Jul 03, 2025, 2:10 PM
    14.25
    -4.94%
    After-hours: Jul 03, 2025, 02:10 PM EDT

    vTv Therapeutics Statistics

    Share Statistics

    vTv Therapeutics has 2.62M shares outstanding. The number of shares has increased by 7.58% in one year.

    Shares Outstanding

    n/a
    		 2.62M

    Shares Change (YoY)

    n/a
    		 7.58%

    Shares Change (QoQ)

    n/a
    		 0.19%

    Owned by Institutions (%)

    n/a
    		 9.55%

    Shares Floating

    n/a
    		 1.49M

    Failed to Deliver (FTD) Shares

    n/a
    		 82

    FTD / Avg. Volume

    n/a
    		 0.93%

    Short Selling Information

    The latest short interest is 18K, so 0.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 18K

    Short % of Shares Out

    n/a
    		 0.69%

    Short % of Float

    n/a
    		 1.62%

    Short Ratio (days to cover)

    n/a
    		 6.26

    Valuation Ratios

    The PE ratio is -4.32 and the forward PE ratio is -4.16. vTv Therapeutics's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -4.32

    Forward PE

    n/a
    		 -4.16

    PS Ratio

    n/a
    		 78.37

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 6.53

    P/FCF Ratio

    n/a
    		 -3.15

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for vTv Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.34, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 7.34

    Quick Ratio

    n/a
    		 7.34

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $44,217.39

    Profits Per Employee

    n/a
    		 $-802,695.65

    Employee Count

    n/a
    		 23

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 100K

    Effective Tax Rate

    n/a
    		 -0.44%

    Stock Price Statistics

    The stock price has increased by -18% in the last 52 weeks. The beta is 0.6, so vTv Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.6

    52-Week Price Change

    n/a
    		 -18%

    50-Day Moving Average

    n/a
    		 18.22

    200-Day Moving Average

    n/a
    		 16.41

    Relative Strength Index (RSI)

    n/a
    		 41.05

    Average Volume (20 Days)

    n/a
    		 8,780

    Income Statement

    In the last 12 months, vTv Therapeutics had revenue of 1.02M and earned -18.46M in profits. Earnings per share was -3.2.

    Revenue

    n/a
    		 1.02M

    Gross Profit

    n/a
    		 928K

    Operating Income

    n/a
    		 -24.18M

    Net Income

    n/a
    		 -18.46M

    EBITDA

    n/a
    		 -22.52M

    EBIT

    n/a
    		 -22.61M

    Earnings Per Share (EPS)

    n/a
    		 -3.2
    Full Income Statement

    Balance Sheet

    The company has 36.75M in cash and 169K in debt, giving a net cash position of 36.58M.

    Cash & Cash Equivalents

    n/a
    		 36.75M

    Total Debt

    n/a
    		 169K

    Net Cash

    n/a
    		 36.58M

    Retained Earnings

    n/a
    		 -299.72M

    Total Assets

    n/a
    		 32.03M

    Working Capital

    n/a
    		 27.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -25.31M and capital expenditures 0, giving a free cash flow of -25.31M.

    Operating Cash Flow

    n/a
    		 -25.31M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -25.31M

    FCF Per Share

    n/a
    		 -4.39
    Full Cash Flow Statement

    Margins

    Gross margin is 91.25%, with operating and profit margins of -2377.58% and -1815.34%.

    Gross Margin

    n/a
    		 91.25%

    Operating Margin

    n/a
    		 -2377.58%

    Pretax Margin

    n/a
    		 -2222.71%

    Profit Margin

    n/a
    		 -1815.34%

    EBITDA Margin

    n/a
    		 -2213.96%

    EBIT Margin

    n/a
    		 -2377.58%

    FCF Margin

    n/a
    		 -2488.4%

    Dividends & Yields

    VTVT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VTVT is $35.5, which is 136.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $35.5

    Price Target Difference

    n/a
    		 136.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 21, 2023. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Nov 21, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 -12.9

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist